CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB) (Middle Region) Peptide
CEBPB
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all CEBPB products
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GGAGMAAGFP YALRAYLGYQ AVPSGSSGSL STSSSSSPPG TPSPADAKAP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- CEBPB Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- Background
-
This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain. The encoded protein functions as a homodimer but can also form heterodimers with CCAAT/enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. The use of alternative in-frame AUG start codons results in multiple protein isoforms, each with distinct biological functions.
Alias Symbols: TCF5, IL6DBP, NF-IL6, C/EBP-beta
Protein Size: 345 - Gene ID
- 1051
- NCBI Accession
- NM_001285878, NP_001272807
- UniProt
- P17676
-
You are here:
